Early esophageal squamous cell carcinoma in a western series is not associated with active HPV infection

Virchows Arch. 2020 Nov;477(5):697-704. doi: 10.1007/s00428-020-02860-2. Epub 2020 Jun 10.

Abstract

Few data are available concerning human papillomavirus (HPV) in early esophageal squamous cell carcinoma (ESCC) in Western population. Our study intended to determine the prevalence of HPV infection and the histological characteristics in such early tumors. A monocentric and retrospective study was conducted including 86 patients with early ESCC treated by endoscopic resection or esophagectomy, from 2012 to 2018. Histopathological prognostic criteria were evaluated. Immunohistochemistry for p16 and p53 and an HPV mRNA in situ hybridization were performed. The tumors were composed of 25 (29%) in situ carcinomas, 21 (24%) intramucosal carcinomas, and 40 (47%) submucosal carcinomas, of which 34 had a deep infiltration (> 200 μm). Emboli, present in 12 cases, were associated with deep infiltration. P16-positive ESCC accounted for 21% of the patients. It was not correlated with active HPV infection as no cases were found to be positive in RISH analysis for RNA detection of this virus. However, there was a correlation between p16 expression and alcohol or tobacco consumption. The only histopathological criterion correlated with p16 positivity was marked inflammatory infiltrate. Local or distant neoplastic recurrence occurred in 25% of patients. Overall survival was 95.8% and local or metastatic recurrence-free survival was 75%. There was a correlation between positive resection margins and tumor recurrence. In contrast to oropharynx carcinoma, our study showed that ESCC were not associated with an active HPV infection, highlighting the negligible role of this virus in early ESCC carcinogenesis in the Western world.

Keywords: Esophagus; HPV; Squamous cell carcinoma; p16-positive.

MeSH terms

  • Aged
  • Biomarkers, Tumor / analysis
  • Cyclin-Dependent Kinase Inhibitor p16 / analysis
  • Esophageal Neoplasms / epidemiology*
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / surgery
  • Esophageal Neoplasms / virology
  • Esophageal Squamous Cell Carcinoma / epidemiology*
  • Esophageal Squamous Cell Carcinoma / secondary
  • Esophageal Squamous Cell Carcinoma / surgery
  • Esophageal Squamous Cell Carcinoma / virology
  • Esophagectomy
  • Female
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Male
  • Margins of Excision
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm, Residual
  • Papillomaviridae / genetics
  • Papillomavirus Infections / diagnosis
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / virology
  • Paris
  • Prevalence
  • RNA, Viral / genetics
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • Tumor Suppressor Protein p53 / analysis

Substances

  • Biomarkers, Tumor
  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • RNA, Viral
  • TP53 protein, human
  • Tumor Suppressor Protein p53